Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Porton Biologics
Suzhou, Jiangsu, Chinaportonpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Porton Biologics provides end-to-end contract development and manufacturing services for gene therapies, cell therapies, plasmids, viral vectors, monoclonal antibodies, ADCs/AOCs/PDCs/RDCs. It enables clients’ programs from early research through clinical trials to commercial production. No proprietary clinical results as it is a service provider[1][5][6].
- Modalities
- Plasmid DNAViral vectorCell therapyGene therapy productsMonoclonal antibody (via parent company platform)Antibody-drug conjugate (via parent company platform)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Dragon Sail Pharmaceutical (antibody-drug conjugates)Aojin Life Sciences (XDC drugs/CDMO partnership)
Beyond the preview
Go deeper on Porton Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Porton Biologics.